Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Outstanding Shares 40,463,303 03/04/2020
Very low float ...
Acquisitions coming based on this PR
Float 5,157,593 02/10/2020
Charlestowne Premium also has Wholesaler and Import permits from the Alcohol and Tobacco Tax and Trade Bureau - the governing body for spirits in the U.S. under the Department of the Treasury.
Charlestowne Premium Beverages Inc (OTC Pink: FPWM) is a company that develops, produces, markets and distributes alcoholic beverages worldwide. The Company's portfolio showcases several current spirit brands such as Papa Vodka, and has developed and marketed other proprietary brands for a variety of customers and clients. These include Crocodile Tears Vodka, Lord ReProprietor's Reserve Whiskey, and Special Reserve Whiskey.
He further stated, "We have identified a team of qualified professionals to implement our strategy and mandate, including experienced accounting and legal representation to implement this agenda. Furthermore, Charlestowne Premium Beverages Inc will seek a more transparent dialogue with its investors by providing clarity and detail throughout the reporting process. As we meet specific milestones, the investment community will be more aware of our activities and developments through our frequent press releases, disclosures and available public records."
Charlestowne Premium Beverages Inc CEO Martin Ustin said: "This new plan and strategy is necessary to attract investment and equity into our company. We want to restore investor confidence, so we are committing to remove affiliate and non-affiliate debt, become fully reporting with the SEC, and file audited financial statements. We are committed to achieving these goals in the next six to nine months, with transparency and teamwork driving our resolve."
The Company has been actively pursuing a niche in the alcoholic beverage market by promoting natural hemp CBD-infused alcoholic beverages.
The next in the strategy aims to increase Net Stockholders' Equity in the Company by investing and acquiring viable brands, businesses operations and/or assets.
Next, Charlestowne Premium plans to audit its financial statements and file a Form Ten (10) to become an OTCQB company this year, increasing transparency for investors and enhancing liquidity
The Company has already taken steps to enhance its public disclosure on OTC Markets by going from a "stop sign" designation back to "Current" in its filing obligations. .
Yes this is a hold, will slowly head up on low volume imo
Slowly building up
Just a matter of time
Only good to come this year
0.0027 ask
Let's see what's up after the bell
0.01+ for sure this year
Should keep rising
300% upside potential based on Goldman Target
Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.
Goldman also cited in the update that since his initiation of coverage report released on February 13, 2020, the HIPH stock price has already risen by 28%, with room to move much higher, based on future business development and revenue expectations. Both the report and the update, along with the associated disclosure and disclaimers can be read or downloaded on the Goldman Small Cap Research website here.
"In our view, this news serves as a transformational event for HIPH. First, it will foster cross-selling opportunities for HIPH that leverages the Q4 platform which could evolve into new, additional distribution. Second, HIPH can now reach a diverse and new demographics for its CBD offerings---that has heretofore not been widely targeted by HIPH's peers, " according to the Goldman Small Cap Research update.
In the sponsored research update, analyst Rob Goldman affirms his price target of $0.0125 and his investment thesis, noting that the news reflects a milestone event that is wide-reaching for the Company in terms of revenue, cross-selling opportunities, and a reach into new markets.
American Premium Water Corporation (OTC PINK:HIPH) announces today that Goldman Small Cap Research, a sponsored research provider focused on microcap stocks, has issued a new research update this morning. This update highlights the impact of the Company closing its distribution agreement with Q4 Sports (www.q4sports.com).
“The Company has made international expansion one of its core priorities in 2019. As we announced earlier this year, the Company has been engaged in discussions with distributors across the globe. Thailand is another country in our growing international network of distribution and it won’t be the last. The Company is presently engaged in discussions with a number of other distributors across the globe. As I have said from the beginning of the year, I feel that the worldwide opportunity in the CBD space is too large to ignore, especially with our unique technology. The combination of our burgeoning worldwide distribution network and cutting edge nano technology separates us from our peers. As we look towards 2020, we are moving full speed ahead with an emphasis on product development and distribution expansion. We are about to unveil new products utilizing our proprietary technology that take advantage of new customer trends, including the pain-relief spray that I mentioned. While the Company adjusts to the regulatory environment, we are moving fast to take advantage of distribution opportunities both domestically and internationally. It has taken longer than I would have liked, but the Company is making progress in executing its business plan; our announcement today is one small feather to add to the cap. As we head into 2020, there are more agreements both internationally and domestically on the way. I look forward to keeping shareholders updated about our progress with these developments as soon as I am able to,” concluded Mr. Fishoff.
American Premium Water Corporation CEO Ryan Fishoff stated, “I am thrilled to announce that the Company’s products will be soon sold in Thailand. With legalization regime underway in the country, the Company is excited to be at the forefront of the of the CBD industry in one of the largest economies in Southeast Asia. Thailand will also be the first international country where we will be launching our American Premium brand of CBD topical products. We feel that the American Premium brand has a lot of potential internationally; it connects to consumers that the US has been the main innovator in CBD technology. Making this connection to foreign consumers is important, and we think the ‘American Premium’ brand encapsulates this. In addition to topical balms, we will also be debuting a pain relief topical spray derived from our proprietary nano-formulation. Topicals are just the beginning of our program in Thailand; as the local laws permit, we look forward to expanding our product offerings to beverages in 2020.
American Premium Water Corporation (OTC: HIPH) (“the Company”) will begin selling CBD infused topical products in Thailand under the brands plant + body essentials (www.plantbodyessentials.com) and American Premium. Thailand will represent the first international distribution of the Company’s American Premium brand of products that were launched in July with Jack Brewer. The first batch of products will be shipped out before the end of the year.
Thailand recently legalized CBD-infused topicals; CBD-infused water to follow as ingestible products become legal in the country in 2020
American Premium Water Corporation (OTC: HIPH) (“the Company”) recently announced that Canyon Create Corp, the manufacturer of Vanexxe, has entered into a Letter of Intent (LOI) with Nutra Pty. Ltd. (Nutra), an Australian corporation with extensive reach in distribution of personal products, to engage in the licensed production and sale of Vanexxe throughout Australia and Southeast Asia. The Company has an equitable interest in Canyon Create Corp.
The LOI also provides for Vanexxe to be evaluated by the TGA, Australia’s health governing body, to be approved for therapeutic use in the world’s 14th largest economy
The company recently expanded Vanexxe Product Distribution in Australia
Yes let's have another green day tomorrow
Let's see if can head back above 0.0050 this week
Yes 0.01 just a few ticks away